Cambrex Long Term Debt 2006-2019 | CBM

Cambrex long term debt from 2006 to 2019. Long term debt can be defined as the sum of all long term debt fields.
Cambrex Annual Long Term Debt
(Millions of US $)
2018 $300
2017 $
2016 $
2015 $
2014 $60
2013 $79
2012 $64
2011 $98
2010 $116
2009 $121
2008 $124
2007 $102
2006 $159
2005 $187
Cambrex Quarterly Long Term Debt
(Millions of US $)
Q2 2019 $529
Q1 2019 $522
Q4 2018 $300
Q3 2018 $325
Q2 2018
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015 $30
Q2 2015 $60
Q1 2015 $60
Q4 2014 $60
Q3 2014 $60
Q2 2014 $74
Q1 2014 $60
Q4 2013 $79
Q3 2013 $101
Q2 2013 $87
Q1 2013 $73
Q4 2012 $64
Q3 2012 $68
Q2 2012 $80
Q1 2012 $84
Q4 2011 $98
Q3 2011 $99
Q2 2011
Q1 2011 $118
Q4 2010 $116
Q3 2010 $114
Q2 2010 $100
Q1 2010 $124
Q4 2009 $121
Q3 2009 $124
Q2 2009 $123
Q1 2009 $127
Q4 2008 $124
Q3 2008 $121
Q2 2008 $116
Q1 2008 $120
Q4 2007 $102
Q3 2007 $97
Q2 2007 $86
Q1 2007
Q4 2006 $159
Q3 2006 $182
Q2 2006 $186
Q1 2006 $168
Q4 2005 $187
Q3 2005 $183
Q2 2005 $200
Q1 2005 $235
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.010B $0.532B
Cambrex Corporation is an innovative life sciences company with a refreshingly human approach. Driven by passion, their pharmaceutical products, expertise and technologies accelerate customers' small molecule therapeutics into markets across the world. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. Cambrex has transformed from a fine chemical manufacturer to a business with a singular focus on small molecule therapeutics.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.673B 13.86
Gilead Sciences (GILD) United States $81.699B 10.03
CSL (CSLLY) Australia $74.842B 0.00
Celgene (CELG) United States $71.151B 11.01
Illumina (ILMN) United States $45.616B 53.59
Vertex Pharmaceuticals (VRTX) United States $44.619B 48.22
Biogen (BIIB) United States $41.641B 7.40
Regeneron Pharmaceuticals (REGN) United States $33.547B 15.23
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.723B 11.98
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.152B 0.00
Incyte (INCY) United States $16.659B 49.03
Seattle Genetics (SGEN) United States $13.329B 0.00
Exact Sciences (EXAS) United States $12.282B 0.00
Genmab (GNMSF) Denmark $12.097B 67.86
BioMarin Pharmaceutical (BMRN) United States $12.067B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.647B 51.72
Alnylam Pharmaceuticals (ALNY) United States $8.801B 0.00
Galapagos (GLPG) Belgium $8.558B 0.00
Bio-Techne Corp (TECH) United States $7.583B 52.38
Sarepta Therapeutics (SRPT) United States $6.371B 0.00
QIAGEN (QGEN) Netherlands $6.143B 20.18
Guardant Health (GH) United States $5.967B 0.00
BeiGene (BGNE) Cayman Islands $5.817B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.704B 0.00
Amarin (AMRN) Ireland $5.519B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.086B 12.93
Exelixis (EXEL) United States $4.962B 12.90
Bluebird Bio (BLUE) United States $4.907B 0.00
Moderna (MRNA) United States $4.599B 0.00
China Biologic Products (CBPO) China $4.526B 28.25
ARGENX SE-ADR (ARGX) Netherlands $4.253B 0.00
Medicines (MDCO) United States $4.141B 0.00
Ascendis Pharma (ASND) Denmark $3.986B 0.00
Repligen (RGEN) United States $3.981B 77.25
Spark Therapeutics (ONCE) United States $3.797B 0.00
Blueprint Medicines (BPMC) United States $3.534B 0.00
MorphoSys AG (MOR) Germany $3.402B 0.00
Reata Pharmaceuticals (RETA) United States $3.028B 0.00
Mirati Therapeutics (MRTX) United States $3.024B 0.00
Alkermes (ALKS) Ireland $2.810B 0.00
Emergent Biosolutions (EBS) United States $2.707B 40.67
Immunomedics (IMMU) United States $2.699B 0.00
Genomic Health (GHDX) United States $2.601B 48.78
Genmab (GMAB) Denmark $2.547B 0.00
MyoKardia (MYOK) United States $2.458B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.403B 0.00
Arena Pharmaceuticals (ARNA) United States $2.358B 5.07
Halozyme Therapeutics (HALO) United States $2.297B 0.00
RA PHARMCTL INC (RARX) United States $2.207B 0.00
Myriad Genetics (MYGN) United States $2.192B 23.01
Acceleron Pharma (XLRN) United States $2.121B 0.00
NeoGenomics (NEO) United States $2.046B 109.44
Amicus Therapeutics (FOLD) United States $2.022B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.005B 0.00
Ligand Pharmaceuticals (LGND) United States $1.991B 25.17
Intercept Pharmaceuticals (ICPT) United States $1.989B 0.00
Zai Lab (ZLAB) China $1.942B 0.00
Akcea Therapeutics (AKCA) United States $1.819B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.586B 0.00
UniQure (QURE) Netherlands $1.586B 0.00
Insmed (INSM) United States $1.522B 0.00
Denali Therapeutics (DNLI) United States $1.437B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.401B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.326B 0.00
REGENXBIO (RGNX) United States $1.281B 0.00
Coherus BioSciences (CHRS) United States $1.255B 0.00
Zymeworks (ZYME) Canada $1.101B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.093B 0.00
Innoviva (INVA) United States $1.084B 3.13
Alector (ALEC) United States $1.010B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.003B 0.00
Editas Medicine (EDIT) United States $0.982B 0.00
Sangamo Therapeutics (SGMO) United States $0.929B 0.00
Fate Therapeutics (FATE) United States $0.924B 0.00
AnaptysBio (ANAB) United States $0.916B 0.00
Epizyme (EPZM) United States $0.911B 0.00
ANI Pharmaceuticals (ANIP) United States $0.860B 14.36
Athenex (ATNX) United States $0.837B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.805B 0.00
Anika Therapeutics (ANIK) United States $0.785B 27.78
Pharming Group (PHGUF) Netherlands $0.782B 0.00
Codexis (CDXS) United States $0.777B 0.00
Cara Therapeutics (CARA) United States $0.755B 0.00
Twist Bioscience (TWST) United States $0.746B 0.00
Zealand Pharma (ZEAL) Denmark $0.738B 8.28
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
Principia Biopharma (PRNB) United States $0.705B 364.63
ZIOPHARM Oncology Inc (ZIOP) United States $0.697B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.689B 24.89
WAVE Life Sciences (WVE) Singapore $0.681B 0.00
Cytokineticsorporated (CYTK) United States $0.654B 0.00
Vericel (VCEL) United States $0.636B 0.00
Mesoblast (MESO) Australia $0.620B 0.00
Revance Therapeutics (RVNC) United States $0.618B 0.00
Heska (HSKA) United States $0.570B 73.87
Arvinas (ARVN) United States $0.562B 0.00
GENFIT S.A (GNFT) France $0.550B 0.00
MiMedx (MDXG) United States $0.550B 0.00
Intellia Therapeutics (NTLA) United States $0.533B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.496B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.488B 0.00
PHARMA MAR SA (PHMMF) Spain $0.482B 0.00
Retrophin (RTRX) United States $0.478B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.443B 0.00
BioDelivery Sciences (BDSI) United States $0.430B 0.00
Intra-Cellular Therapies (ITCI) United States $0.429B 0.00
DBV Technologies S.A (DBVT) France $0.427B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.424B 0.00
Cellectis S.A (CLLS) France $0.413B 0.00
Adverum Biotechnologies (ADVM) United States $0.393B 0.00
Stemline Therapeutics (STML) United States $0.382B 0.00
Syros Pharmaceuticals (SYRS) United States $0.370B 0.00
Agenus (AGEN) United States $0.369B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.368B 0.00
Arcus Biosciences (RCUS) United States $0.367B 0.00
Bellus Health (BLU) Canada $0.366B 0.00
Merus (MRUS) Netherlands $0.361B 0.00
Precision BioSciences (DTIL) United States $0.349B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.344B 0.00
Kadmon Holdings (KDMN) United States $0.337B 0.00
AC Immune SA (ACIU) Switzerland $0.335B 24.80
CytomX Therapeutics (CTMX) United States $0.320B 0.00
Prothena (PRTA) Ireland $0.311B 0.00
Gritstone Oncology (GRTS) United States $0.307B 0.00
Protagonist Therapeutics (PTGX) United States $0.300B 0.00
Avid Bioservices (CDMO) United States $0.298B 0.00
Theratechnologies (THTX) Canada $0.291B 0.00
Cellular Biomedicine (CBMG) United States $0.285B 0.00
Pfenex (PFNX) United States $0.283B 0.00
Starpharma Holdings (SPHRY) Australia $0.279B 0.00
Geron (GERN) United States $0.275B 0.00
Cel-Sci (CVM) United States $0.275B 0.00
Kindred Biosciences (KIN) United States $0.273B 0.00
PDL BioPharma (PDLI) United States $0.273B 7.03
Scholar Rock Holding (SRRK) United States $0.269B 0.00
Dynavax Technologies (DVAX) United States $0.266B 0.00
Biofrontera AG (BFRA) Germany $0.265B 395.33
Puma Biotechnology (PBYI) United States $0.264B 0.00
MannKind (MNKD) United States $0.245B 0.00
Prometic Life Sciences (PFSCF) Canada $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.232B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.230B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.217B 0.00
Sutro Biopharma (STRO) United States $0.216B 0.00
Albireo Pharma (ALBO) United States $0.215B 0.00
Seres Therapeutics (MCRB) United States $0.214B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.213B 0.00
OSMOTICA PHARM (OSMT) United States $0.212B 0.00
Inovio Pharmaceuticals (INO) United States $0.211B 0.00
Compugen (CGEN) Israel $0.206B 0.00
Sorrento Therapeutics (SRNE) United States $0.206B 0.00
Athersys (ATHX) United States $0.205B 0.00
Exicure (XCUR) United States $0.204B 0.00
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Kamada (KMDA) Israel $0.203B 7.77
Spero Therapeutics (SPRO) United States $0.202B 0.00
Palatin Technologies (PTN) United States $0.186B 5.45
ChromaDex (CDXC) United States $0.182B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Dyadic (DYAI) United States $0.173B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.173B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.172B 0.00
Clovis Oncology (CLVS) United States $0.171B 0.00
Affimed (AFMD) Germany $0.167B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Cue Biopharma (CUE) United States $0.159B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.159B 0.00
Enzo Biochem (ENZ) United States $0.158B 0.00
XOMA (XOMA) United States $0.156B 0.00
Alcobra (ARCT) United States $0.151B 0.00
Senesco Technologies (ELOX) United States $0.151B 0.00
Cerecor (CERC) United States $0.151B 0.00
Five Prime Therapeutics (FPRX) United States $0.150B 0.00
Arsanis (XFOR) United States $0.144B 0.00
BioTime (LCTX) United States $0.139B 9.30
Northwest Biotherapeutics (NWBO) United States $0.136B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.133B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
CorMedix Inc (CRMD) United States $0.126B 0.00
NantKwest (NK) United States $0.118B 0.00
SESEN BIO, INC (SESN) United States $0.117B 0.00
Acorda Therapeutics (ACOR) United States $0.115B 0.00
PHASEBIO PHARMA (PHAS) United States $0.113B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
Novavax (NVAX) United States $0.112B 0.00
Menlo Therapeutics (MNLO) United States $0.109B 0.00
Strongbridge Biopharma (SBBP) United States $0.107B 4.40
Abeona Therapeutics (ABEO) United States $0.107B 0.00
Emmaus Life Sciences (EMMA) United States $0.107B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.107B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.104B 0.00
Celyad SA (CYAD) Belgium $0.098B 0.00
Aptinyx (APTX) United States $0.095B 0.00
OvaScience (MLND) United States $0.095B 0.00
Trevena (TRVN) United States $0.091B 0.00
VBI Vaccines (VBIV) United States $0.090B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
Fortress Biotech (FBIO) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Verastem (VSTM) United States $0.081B 0.00
ARAVIVE, INC (ARAV) United States $0.080B 0.00
Aduro Biotech (ADRO) United States $0.079B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.078B 0.00
Checkpoint Therapeutics (CKPT) United States $0.077B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Liquidia Technologies (LQDA) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.071B 0.00
Mersana Therapeutics (MRSN) United States $0.071B 0.00
Curis (CRIS) United States $0.069B 0.00
Synlogic (SYBX) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.065B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.064B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Selecta Biosciences (SELB) United States $0.063B 0.00
Orgenesis (ORGS) United States $0.058B 21.06
Catabasis Pharmaceuticals (CATB) United States $0.057B 0.00
Pluristem Therapeutics (PSTI) Israel $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.054B 0.00
Arbutus Biopharma (ABUS) Canada $0.053B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.052B 0.00
AquaBounty Technologies (AQB) United States $0.051B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
VistaGen Therapeutics (VTGN) United States $0.047B 0.00
Unum Therapeutics (UMRX) United States $0.045B 0.00
AIT Therapeutics (XAIR) United States $0.045B 0.00
NewLink Genetics (NLNK) United States $0.044B 0.00
Stellar Biotechnologies (EDSA) Canada $0.043B 0.00
Evogene (EVGN) Israel $0.042B 0.00
Ophthotech (ISEE) United States $0.041B 0.00
VIVUS (VVUS) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
Proteostasis Therapeutics (PTI) United States $0.040B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.040B 0.00
Organovo Holdings (ONVO) United States $0.039B 0.00
Oncobiologics (OTLK) United States $0.037B 0.00
Celsion (CLSN) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Entera Bio (ENTX) Israel $0.034B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.90
Clearside Biomedical (CLSD) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
DiaMedica Therapeutics (DMAC) United States $0.026B 0.00
Protalix BioTherapeutics (PLX) Israel $0.026B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Apricus Biosciences (SEEL) United States $0.020B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.020B 0.00
Soligenix (SNGX) United States $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
Pulmatrix (PULM) United States $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Cleveland BioLabs (CBLI) United States $0.011B 0.00
IBio (IBIO) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
TrovaGene (TROV) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (CUR) United States $0.003B 0.00